Clinical Trial Update: A Prospective Study Utilizing Circulating Cell Free DNA (cfDNA) Use in the Detection of RAS Mutations in Patients With Advanced Colorectal Cancer. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring circulating cell-free DNA for detecting RAS mutations in advanced colorectal cancer (Colorectal cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: National Guard Health Affairs | Conditions: Colon Cancer | Phase 2 | Status: UNKNOWN